Dutch government updates dashboard tracking medicine reimbursement delays
The Dutch government has updated its medicines reimbursement dashboard with new search filters, explanations and a glossary, making it easier to follow the stages of assessments and price negotiations.
Review information is loading.
The Dutch government has revamped its online dashboard showing how long new medicines take to move through the reimbursement process, adding filters and explanations intended to make the information easier to find and interpret.
The dashboard tracks three stages: a manufacturer submitting a reimbursement dossier to the National Health Care Institute (Zorginstituut Nederland), the institute assessing the medicine, and price negotiations between the manufacturer and the health ministry.
Users can now search by manufacturer, condition and reimbursement status. The updated tool also explains each stage and includes a glossary. The government says patients, pharmacists, prescribers and pharmaceutical companies contributed their experiences and suggestions to the redesign.
In the Netherlands, many medicines are reimbursed automatically through basic health insurance, but some new drugs may be temporarily excluded while the institute assesses their effectiveness and whether their price is proportionate to the health benefits. If it concludes the price is not, the institute can advise the health ministry to negotiate with the manufacturer.
Sign in to give this article a thumbs up or down.
About this discussion and AI questions
Private test discussion. Comments are readers’ views and are not yet automatically fact-checked. Editing is available for 60 seconds after posting.
Sign in with a confirmed reader account and choose a username to read comments and participate.
Sorting applies to top-level comments; replies remain oldest first. New comments and likes can change the order. Refresh for the current ranking.
Loading comments…